Karyopharm Therapeutics Inc. ($KPTI)
Filing Information
| Accession Number | 0001193125-26-226652 |
|---|---|
| Form Type | 4 |
| Filing Date | May 15, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,271
Total Value
$3,078.00
P&L
+inf% (+$7,263.49)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Commercial Officer | Common Stock | โ | May 13, 2026 | Grant/Award | 947 | $0.00 | $0.00 | 108,264 | Direct | โ | View Details | |
EVP & Chief Commercial Officer | Common Stock | โ | May 14, 2026 | Sale | 324 | $9.50 | $3,078.00 | 107,940 | Direct | โ | View Details |